Last update 01 Nov 2024

Lemzoparlimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-CD47 antibody ( I-Mab)
+ [1]
Target
Mechanism
CD47 inhibitors(Cluster of differentiation 47 inhibitors)
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Myelodysplastic SyndromesPhase 3
CN
30 Mar 2023
Acute Myeloid LeukemiaPhase 2
CN
08 May 2021
Adult Acute Myeloblastic LeukemiaPhase 2
CN
25 Mar 2020
Refractory acute myeloid leukemiaPhase 2
CN
25 Mar 2020
Relapsing acute myeloid leukemiaPhase 2
CN
25 Mar 2020
LymphomaPhase 1
CN
16 Apr 2019
LymphomaPhase 1
US
16 Apr 2019
Bone Marrow NeoplasmsDiscovery
DE
17 Jan 2022
Advanced Malignant Solid NeoplasmDiscovery
CN
30 Dec 2021
Multiple MyelomaDiscovery
US
28 Aug 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
53
-
(bmbrjialgl) = nepbdoaguq yoopdpumpu (nczjogapky )
Positive
10 Sep 2022
(initial treatment ≥ 4 mo)
(drsvrmmcko) = qslocgwgau hnvqdwmtyf (ftxtczwugu )
Phase 1
9
Lemzoparlimab+Rituximab
(ovhlkjniol) = jorwhcgarj omfqgxwhhn (kixvdhahwx )
Positive
14 Dec 2021
Phase 1
20
smefnjhnhi(bunmxrgspp) = ahhbrazqic zdhavvenct (kkpnyglqaz )
Positive
10 Dec 2020
Phase 1
5
(uoahmjgguk) = none kkvdyladqa (ykxqqsjhuz )
Positive
05 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free